Literature DB >> 12045494

HIV prevalence and risk behaviour in young drug users in Amsterdam.

Esther A E Welp1, Aart C Lodder, Miranda W Langendam, Roel A Coutinho, Erik J C van Ameijden.   

Abstract

OBJECTIVES: To assess the HIV prevalence and risk behaviour among regular young drug users (YDU) in Amsterdam.
DESIGN: Subjects were 282 YDU (using heroin, cocaine, methadone and/or amphetamines at least 3 days/week) aged 30 years or less who participated in a cross-sectional survey in Amsterdam in 1998. Participants were recruited both directly (41%) through healthcare institutions, and indirectly (59%) by referrals from YDU already enrolled. A comparison sample of YDU from the Amsterdam Cohort Study recruited between 1985 and 1989 was used to describe trends in HIV prevalence and risk behaviour.
RESULTS: Mean age was 25 years, 22% were women, 39% had at least once injected drugs, and 22% currently injected in 1998. Cocaine was more often used regularly (70%) than heroin (42%). Of the 282 YDU, 21 (7.4%) were infected with HIV. Among those who had injected drugs, HIV prevalence was 16.2%. Among those who had never injected, the prevalence of HIV infection was 1.8%. A history of injecting declined from 83% in 1985-1989 to 56% in 1998. Compared with 1985-1989, the lack of a recent steady partner appeared to be an important risk factor for a positive HIV status among injectors in 1998, whereas borrowing of used needles/syringes was no longer a risk factor.
CONCLUSION: The use of cocaine among YDU is very popular in Amsterdam. A strong decrease in injecting behaviour has taken place, but among those who inject, risk behaviour is still considerable, and HIV infection is still widespread. Preventative activities should be expanded, specifically among YDU.

Entities:  

Mesh:

Year:  2002        PMID: 12045494     DOI: 10.1097/00002030-200206140-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  3 in total

1.  Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

Authors:  Luis de la Fuente; María José Bravo; Carlos Toro; M Teresa Brugal; Gregorio Barrio; Vicente Soriano; Fernando Vallejo; Rosario Ballesta
Journal:  J Epidemiol Community Health       Date:  2006-06       Impact factor: 3.710

2.  Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.

Authors:  G Barrio; L De La Fuente; C Toro; T M Brugal; V Soriano; F Gonzalez; M J Bravo; F Vallejo; T C Silva
Journal:  Epidemiol Infect       Date:  2006-09-28       Impact factor: 2.451

Review 3.  Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective.

Authors:  Daniela K van Santen; Roel A Coutinho; Anneke van den Hoek; Giel van Brussel; Marcel Buster; Maria Prins
Journal:  Harm Reduct J       Date:  2021-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.